Complete PSA Response Following Stereotactic Ablative Radiotherapy for a Bony Metastasis in the Setting of Castrate-Resistant Prostate Cancer

A majority of patients with castrate-resistant prostate cancer ultimately develop distant metastases, with bone being the most common site of spread. Classically, systemic therapy has been considered the standard of care for patients with metastatic cancer. Emerging evidence, however, suggests that...

Descripción completa

Detalles Bibliográficos
Autores principales: Lukovic, Jelena, Rodrigues, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2015
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659582/
https://www.ncbi.nlm.nih.gov/pubmed/26623220
http://dx.doi.org/10.7759/cureus.365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659582/
https://www.ncbi.nlm.nih.gov/pubmed/26623220
http://dx.doi.org/10.7759/cureus.365

Ejemplares similares